Skip to Content
Merck
CN

444839

4(5)-(Iodoacetamido)fluorescein

Dye content 90 %

Synonym(s):

IAF

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C22H14INO6
CAS Number:
Molecular Weight:
515.25
UNSPSC Code:
12171500
MDL number:
Beilstein/REAXYS Number:
6543244
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


composition

Dye content, 90%

mp

265-267 °C (dec.) (lit.)

λmax

266 nm in DMF

SMILES string

OC(=O)c1ccc(NC(=O)CI)cc1C2=C3C=CC(=O)C=C3Oc4cc(O)ccc24



Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Claudio Babiloni et al.
NeuroImage. Clinical, 12, 144-156 (2016-07-14)
Here we tested the effect of combined antiretroviral therapy (cART) on deviant electroencephalographic (EEG) source activity in treatment-naïve HIV individuals. Resting state eyes-closed EEG data were recorded before and after 5 months of cART in 48 male HIV subjects, who were
Davide Vito Moretti
Frontiers in neurology, 6, 152-152 (2015-07-29)
Recent studies demonstrate that the alpha3/alpha2 power ratio correlates with cortical atrophy, regional hypoperfusion, and memory impairment in subjects with mild cognitive impairment (MCI). Evidences were reviewed in subjects with MCI, who underwent EEG recording, magnetic resonance imaging (MRI) scans
Roberta Lizio et al.
Journal of Alzheimer's disease : JAD, 49(1), 159-177 (2015-10-08)
Here we presented a single electroencephalographic (EEG) marker for a neurophysiological assessment of Alzheimer's disease (AD) patients already diagnosed by current guidelines. The ability of the EEG marker to classify 127 AD individuals and 121 matched cognitively intact normal elderly